• Relmada Therapeutics Inc. (RLMD) Stock Price | Live Quotes & Charts | NASDAQ timothysykes.com Thu, 09 Jul 2026 00:36:00 GMT
• relmada therapeutics (rlmd) faces minor pullback, testing key support levels - aaii bullish dars.gov.et Sat, 04 Jul 2026 00:44:43 GMT
• enterprise value to ebitda forward of relmada therapeutics, inc. – nasdaq:rlmd TradingView Tue, 30 Jun 2026 19:53:27 GMT
• enterprise value to revenue forward of relmada therapeutics, inc. – nasdaq:rlmd TradingView Tue, 30 Jun 2026 16:45:25 GMT
• Price to book forward of Relmada Therapeutics, Inc. – NASDAQ:RLMD TradingView Tue, 30 Jun 2026 06:31:11 GMT
• relmada therapeutics, inc.(nasdaqcm:rlmd) added to russell small cap comp growth benchmark marketscreener.com Mon, 29 Jun 2026 20:45:32 GMT
• Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 2500 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 19:23:47 GMT
• relmada therapeutics joins russell 2000, russell 3000 indexes marketscreener.com Mon, 29 Jun 2026 18:56:14 GMT
• Relmada Therapeutics added to Russell 2000 and 3000 indexes By Investing.com Investing.com Australia Mon, 29 Jun 2026 11:58:34 GMT
• Relmada Therapeutics (RLMD) Joins Russell 2000 and 3000 Indices GuruFocus Mon, 29 Jun 2026 11:50:49 GMT
• Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes GlobeNewswire Mon, 29 Jun 2026 11:00:00 GMT
• price to earnings forward of relmada therapeutics, inc. – nasdaq:rlmd TradingView Mon, 29 Jun 2026 10:41:36 GMT
• Relmada lands in Russell 2000 and Russell 3000 after reconstitution Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• price to sales forward of relmada therapeutics, inc. – nasdaq:rlmd TradingView Mon, 29 Jun 2026 06:14:00 GMT
• Relmada Therapeutics, Inc.(NasdaqCM: RLMD) added to Russell 3000 Growth Benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• RLMD Jumps As H.C. Wainwright Launches Bullish Coverage timothysykes.com Fri, 26 Jun 2026 20:08:00 GMT
• relmada therapeutics inc actuals & estimates (nasdaq:rlmd) TradingView Fri, 26 Jun 2026 07:35:36 GMT
• relmada therapeutics (rlmd) short interest & short float | updated jun 2026 MarketBeat Thu, 25 Jun 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• Relmada Therapeutics Inc (NASDAQ: RLMD) Share Price, RLMD Stock News, RLMD Share Price & Updates Kalkine Tue, 23 Jun 2026 12:34:53 GMT
• h.c. wainwright reiterates buy rating on relmada therapeutics inc (rlmd) StreetInsider Tue, 23 Jun 2026 10:51:56 GMT
• Relmada Therapeutics stock maintained at Buy by H.C. Wainwright Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• form 13g relmada therapeutics for: 22 june by investing.com Investing.com India Tue, 23 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains relmada therapeutics(rlmd.us) with buy rating, maintains target price $12 Moomoo Tue, 23 Jun 2026 07:00:00 GMT
• form 13g relmada therapeutics for: 22 june by investing.com Investing.com Canada Mon, 22 Jun 2026 21:53:14 GMT
• relmada therapeutics inc (nasdaq: rlmd) share price, rlmd stock news, rlmd share price & updates Kalkine Mon, 22 Jun 2026 20:00:00 GMT
• Millennium Group reports 4.57M Relmada shares (NASDAQ: RLMD) in 13G Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• RLMD Q1 2026 Earnings: Wider-than-Expected Loss Amid Ongoing Clinical Development - Margin Guidance dars.gov.et Mon, 22 Jun 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• relmada therapeutics, inc.(nasdaqcm:rlmd) added to s&p pharmaceuticals select industry index marketscreener.com Mon, 22 Jun 2026 01:27:23 GMT
• Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Pharmaceuticals Select Industry Index marketscreener.com Sun, 21 Jun 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) technical analysis: support, resistance, indicators & moving averages TradingKey Sun, 21 Jun 2026 07:00:00 GMT
• relmada: ndv-01 entering phase 3 in nmibc; no rush to buy stock today (nasdaq:rlmd) Seeking Alpha Fri, 19 Jun 2026 14:47:14 GMT
• relmada therapeutics inc (rlmd) risk assessment: volatility, financial risk & investment risk TradingKey Fri, 19 Jun 2026 09:06:58 GMT
• Relmada: NDV-01 Entering Phase 3 In NMIBC, But There's No Rush To Buy Stock Today Seeking Alpha Fri, 19 Jun 2026 07:00:00 GMT
• Relmada Therapeutics (RLMD): 10 Best Growth Stocks Under $30 to Buy Now Yahoo Finance Fri, 19 Jun 2026 07:00:00 GMT
• rlmd initiates coverage on by hc wainwright & co. -- rating set to buy GuruFocus Thu, 18 Jun 2026 22:10:31 GMT
• H.C. Wainwright Starts Relmada Therapeutics Inc (RLMD) at Buy, PT $12 StreetInsider Thu, 18 Jun 2026 10:01:43 GMT
• Relmada Therapeutics Price Target Announced at $12.00/Share by HC Wainwright & Co. Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• H.C. Wainwright Initiates Relmada Therapeutics(RLMD.US) With Buy Rating, Announces Target Price $12 Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• H.C. Wainwright initiates Relmada stock coverage with buy rating Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:01:45 GMT
• relmada therapeutics inc (rlmd) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:01:05 GMT
• Relmada Therapeutics Inc (RLMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 20:31:01 GMT
• relmada therapeutics inc (rlmd) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 23:19:53 GMT
• relmada therapeutics inc (rlmd) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 21:36:48 GMT
• relmada therapeutics inc (rlmd) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 17:32:51 GMT
• relmada therapeutics inc (rlmd) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 15:29:53 GMT
• relmada therapeutics inc (rlmd) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 13:47:48 GMT
• Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor Indian Pharma Post Sat, 13 Jun 2026 07:00:00 GMT
• relmada therapeutics bolsters sepranolone program with michael quirk as senior advisor Indian Pharma Post Fri, 12 Jun 2026 13:00:00 GMT
• Relmada Therapeutics Appoints CNS Drug Development Veteran GlobeNewswire Thu, 11 Jun 2026 07:00:00 GMT
• Relmada appoints Michael Quirk as senior advisor for sepranolone Investing.com Thu, 11 Jun 2026 07:00:00 GMT
• press release: relmada therapeutics appoints cns drug development veteran michael quirk as senior advisor for sepranolone program 富途牛牛 Thu, 11 Jun 2026 07:00:00 GMT
• Relmada Therapeutics (RLMD) Rises 2.3% as Biotech Stock Tests Support Levels - High Dividend Factor dars.gov.et Wed, 10 Jun 2026 07:00:00 GMT
• venrock-affiliated funds hold 6.2% of relmada (nasdaq: rlmd) Stock Titan Wed, 10 Jun 2026 00:11:16 GMT
• [schedule 13g] relmada therapeutics, inc. passive investment disclosure (>5%) Stock Titan Wed, 10 Jun 2026 00:11:16 GMT
• venrock-affiliated funds hold 6.2% of relmada (nasdaq: rlmd) Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• RLMD: NDV-01 advances to phase III with strong data, broadening access and maintaining solid financials TradingView Thu, 04 Jun 2026 07:00:00 GMT
• rlmd financials: revenue breakdown, margins & competitor comparison Intellectia AI Wed, 03 Jun 2026 13:01:05 GMT
• Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Mov Benzinga Wed, 03 Jun 2026 07:00:00 GMT
• RLMD Q1 2026 Earnings: EPS Misses Estimates as Clinical Development Continues - GAAP Earnings Report dars.gov.et Mon, 01 Jun 2026 07:00:00 GMT
• relmada therapeutics, inc. - common stock (nq: rlmd FinancialContent Fri, 29 May 2026 23:54:12 GMT
• relmada therapeutics (rlmd) to present at the jefferies global healthcare conference StreetInsider Thu, 28 May 2026 11:05:56 GMT
• Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference GlobeNewswire Thu, 28 May 2026 07:00:00 GMT
• Relmada (NASDAQ: RLMD) holders back higher share cap and equity plan Stock Titan Thu, 28 May 2026 07:00:00 GMT
• Relmada Therapeutics - Increases authorized common stock to 200 million shares from 150 million marketscreener.com Thu, 28 May 2026 07:00:00 GMT
• relmada executives to present at jefferies healthcare conference Investing.com Thu, 28 May 2026 07:00:00 GMT
• biotech relmada ceo, cfo in jefferies fireside chat june 4 Stock Titan Thu, 28 May 2026 07:00:00 GMT
• relmada therapeutics inc annual shareholders meeting transcript GuruFocus Wed, 27 May 2026 13:30:00 GMT
• earnings call transcript: relmada therapeutics q1 2026 sees stock dip despite strong cash position Investing.com Tue, 19 May 2026 07:00:00 GMT
• relmada therapeutics, inc. - common stock (nq: rlmd FinancialContent Sun, 17 May 2026 07:19:50 GMT
• relmada targets mid-2026 phase 3 rescue start backed by $234m cash runway through 2029 MSN Fri, 15 May 2026 23:55:38 GMT
• relmada therapeutics, inc. - common stock (nq: rlmd FinancialContent Fri, 15 May 2026 20:00:00 GMT
• wall street analysts predict a 92.19% upside in relmada therapeutics (rlmd): here's what you should know MSN Fri, 15 May 2026 05:38:57 GMT
• relmada therapeutics, inc. - common stock (nq: rlmd FinancialContent Thu, 14 May 2026 17:43:10 GMT
• piper sandler maintains relmada therapeutics(rlmd.us) with buy rating, maintains target price $12 富途牛牛 Thu, 14 May 2026 03:11:36 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Thu, 14 May 2026 01:28:00 GMT
• piper sandler maintains relmada therapeutics(rlmd.us) with buy rating, maintains target price $12 Moomoo Wed, 13 May 2026 12:34:00 GMT
• relmada therapeutics, inc. (nasdaq:rlmd) q1 2026 earnings call transcript Insider Monkey Wed, 13 May 2026 12:24:36 GMT
• relmada therapeutics (nasdaq: rlmd) registers 29.5m shares tied to $160m deal Stock Titan Wed, 13 May 2026 07:00:00 GMT
• relmada therapeutics inc files for mixed shelf offering, size not disclosed - sec filing TradingView Wed, 13 May 2026 07:00:00 GMT
• adage capital reports 4.54% stake in relmada therapeutics (nasdaq: rlmd) Stock Titan Wed, 13 May 2026 07:00:00 GMT
• relmada therapeutics reports strong q1 2026 results, highlights positive ndv-01 phase 2 data in bladder cancer and plans for phase... Minichart Wed, 13 May 2026 07:00:00 GMT
• relmada therapeutics reports first quarter 2026 financial results and provides business update The Manila Times Wed, 13 May 2026 07:00:00 GMT
• rlmd stock price, quote & chart | relmada therapeutics inc (nasdaq:rlmd) ChartMill Wed, 13 May 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) q1 2026 earnings call highlights GuruFocus Wed, 13 May 2026 06:34:04 GMT
• is relmada therapeutics (rlmd) fairly valued after q1 2026? eps: GuruFocus Wed, 13 May 2026 05:10:19 GMT
• relmada targets mid-2026 phase 3 rescue start backed by $234m cash runway through 2029 MSN Wed, 13 May 2026 01:53:54 GMT
• transcript : relmada therapeutics, inc., q1 2026 earnings call, may 12, 2026 marketscreener.com Wed, 13 May 2026 01:21:23 GMT
• rlmd: ndv-01 shows best-in-class efficacy in nmibc; cash and patent position support long-term growth TradingView Tue, 12 May 2026 22:07:39 GMT
• is relmada therapeutics (rlmd) fairly valued after q1 2026? eps: GuruFocus Tue, 12 May 2026 22:04:35 GMT
• rlmd: ndv-01 demonstrates high efficacy in nmibc, with robust financials supporting late-stage trials TradingView Tue, 12 May 2026 21:30:46 GMT
• rlmd: robust ndv-01 phase 2 results and $160m financing support phase 3 launch and long-term funding TradingView Tue, 12 May 2026 20:26:17 GMT
• relmada therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 20:06:00 GMT
• Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 Investing News Network Tue, 12 May 2026 07:00:00 GMT
• Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• Earnings Flash (RLMD) Relmada Therapeutics Posts Q1 Loss $0.22, vs. FactSet Est of $0.20 Loss marketscreener.com Tue, 12 May 2026 07:00:00 GMT
• mizuho securities maintains relmada therapeutics(rlmd.us) with buy rating, maintains target price $19 富途牛牛 Tue, 12 May 2026 07:00:00 GMT
• relmada therapeutics ($rlmd) releases q1 2026 earnings Quiver Quantitative Tue, 12 May 2026 07:00:00 GMT
• transcript: relmada therapeutics q1 2026 earnings conference call Benzinga Tue, 12 May 2026 07:00:00 GMT
• earnings call transcript: relmada therapeutics q1 2026 results reveal mixed performance Investing.com Tue, 12 May 2026 07:00:00 GMT
• bladder cancer drug shows 95% response as relmada readies phase 3 Stock Titan Tue, 12 May 2026 07:00:00 GMT
• relmada therapeutics (nasdaq: rlmd) posts q1 loss, builds cash for ndv-01, sepranolone Stock Titan Tue, 12 May 2026 07:00:00 GMT
• rlmd: ndv-01 demonstrates high response rates in nmibc, with pivotal trials and strong financial backing ahead TradingView Tue, 12 May 2026 07:00:00 GMT
• relmada (nasdaq: rlmd) boosts cash with $160m pipe and ndv-01 data Stock Titan Tue, 12 May 2026 07:00:00 GMT
• relmada therapeutics inc (rlmd) q1 2026 earnings call highlights: strong financial position and ... by gurufocus Investing.com Canada Tue, 12 May 2026 07:00:00 GMT
• relmada therapeutics to report first quarter 2026 financial results on tuesday, may 12, 2026 Investing News Network Sun, 10 May 2026 21:17:21 GMT
• relmada therapeutics, inc. (nasdaq:rlmd) receives consensus recommendation of "moderate buy" from analysts MarketBeat Sat, 09 May 2026 07:00:00 GMT
• relmada therapeutics inc expected to post a loss of 19 cents a share - earnings preview TradingView Fri, 08 May 2026 21:17:06 GMT
• wall street analysts predict a 92.19% upside in relmada therapeutics (rlmd): here's what you should know MSN Fri, 08 May 2026 20:45:50 GMT
• rlmd relmada therapeutics sinks 5.5% on 103% eps miss; cash runway concerns intensify for biotech firm. - pre-earnings setup Newser Fri, 08 May 2026 07:00:00 GMT
Relmada Therapeutics, Inc(NASDAQ:RLMD) 
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, an oral agent, which is in Phase II clinical trial for the treatment of de...
Website: http://www.relmada.com
Founded: 2004
Full Time Employees: 6
CEO: Sergio Traversa
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic